In the early days of the COVID-19 pandemic, Moderna (NASDAQ: MRNA) was a top performer, from both a share-price and an ...

Valued at a market cap of $9.6 billion, Cambridge, Massachusetts-based Moderna, Inc. (MRNA) is a biotechnology company that ...

Furthering its goal to grow the reach of its mRNA vaccines and guard against future pandemics, Moderna cleared a key ...

As the 2020 pandemic became a distant memory and millions of Americans returned back to their old lives, some were left ...

Leerink Partners analyst David Risinger maintained a Sell rating on Moderna (MRNA – Research Report) yesterday and set a price target of ...

US mRNA specialist Moderna (Nasdaq: MRNA) has announced that its manufacturing facility in the UK has been granted a manufacturer’s license by the Medicines and Healthcare products Regulatory Agency ...

The committee endorsed lowering the age at which some people can receive RSV vaccines, but stopped short of recommending ...

One of the largest biotech companies in the country has filed a lawsuit claiming improper building practices led to millions in damages at one of its new manufacturing facilities. Moderna is ...

The far-right government of Giorgia Meloni wants to rehabilitate this movement, which celebrated speed, power, industrial ...

Advancements in mRNA vaccine technology are reshaping medicine, addressing challenges and expanding applications from ...

The U.S. government continues to end contracts related to the $5 billion Project NextGen initiative, this time terminating ...